First headline I read today:
- MarketWatch – Bristol-Myers to acquire Celgene in cash-and-stock deal with equity value of about $74 billion
I closed out the five Jan 18, 2019 Puts I had sold this morning with a *$710.00 profit.
Had I simply bought 500 shares in Celgene Corp (CELG) back in November 2018 instead of selling Puts – I could have sold them for a $6,500.00+ profit!
Serenity Now!
*Excludes transaction costs.
Leave a Reply